Episode

Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel

Podcast
Dermatologic Oncology Update
Published
Mar 28, 2025
Duration seconds
2968
Processing state
not_requested
Canonical source
https://dermatologic.researchtopractice.com/episode/5268-oncologytodaynf24
Audio
https://dts.podtrac.com/redirect.mp3/podcasts.captivate.fm/media/786781f9-20f5-4555-89df-f073b009fbaa/OncologyTodayNF24.mp3
JSON
/v1/public/podcasts/dermatologic-oncology-update-450819/episodes/neurofibromatosis-type-1-plexiform-neurofibromas-an-interview-with-dr-christopher-l-moertel
Markdown
/podcast/dermatologic-oncology-update-450819/neurofibromatosis-type-1-plexiform-neurofibromas-an-interview-with-dr-christopher-l-moertel.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/dermatologic-oncology-update-450819/episodes/neurofibromatosis-type-1-plexiform-neurofibromas-an-interview-with-dr-christopher-l-moertel/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/dermatologic-oncology-update-450819/neurofibromatosis-type-1-plexiform-neurofibromas-an-interview-with-dr-christopher-l-moertel.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associated with neurofibromatosis type 1.  CME information and select publications here .